GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ion Beam Applications SA (XBRU:IBAS) » Definitions » Days Sales Outstanding

Ion Beam Applications (XBRU:IBAS) Days Sales Outstanding : 70.84 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Ion Beam Applications Days Sales Outstanding?

Ion Beam Applications's average Accounts Receivable for the six months ended in Dec. 2023 was €100.65 Mil. Ion Beam Applications's Revenue for the six months ended in Dec. 2023 was €259.30 Mil. Hence, Ion Beam Applications's Days Sales Outstanding for the six months ended in Dec. 2023 was 70.84.

The historical rank and industry rank for Ion Beam Applications's Days Sales Outstanding or its related term are showing as below:

XBRU:IBAS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 69.76   Med: 96.25   Max: 140
Current: 88.81

During the past 13 years, Ion Beam Applications's highest Days Sales Outstanding was 140.00. The lowest was 69.76. And the median was 96.25.

XBRU:IBAS's Days Sales Outstanding is ranked worse than
73.23% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.21 vs XBRU:IBAS: 88.81

Ion Beam Applications's Days Sales Outstanding declined from Dec. 2022 (72.70) to Dec. 2023 (70.84).


Ion Beam Applications Days Sales Outstanding Historical Data

The historical data trend for Ion Beam Applications's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ion Beam Applications Days Sales Outstanding Chart

Ion Beam Applications Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 140.00 130.81 104.50 94.70 93.32

Ion Beam Applications Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.04 70.99 72.70 110.62 70.84

Competitive Comparison of Ion Beam Applications's Days Sales Outstanding

For the Medical Devices subindustry, Ion Beam Applications's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ion Beam Applications's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ion Beam Applications's Days Sales Outstanding falls into.



Ion Beam Applications Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ion Beam Applications's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (111.649 + 107.576) / 2 ) / 428.717*365
=109.6125 / 428.717*365
=93.32

Ion Beam Applications's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (93.728 + 107.576) / 2 ) / 259.299*365 / 2
=100.652 / 259.299*365 / 2
=70.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ion Beam Applications  (XBRU:IBAS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Ion Beam Applications Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ion Beam Applications's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Ion Beam Applications (XBRU:IBAS) Business Description

Traded in Other Exchanges
Address
Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in two segments: proton therapy and other accelerators and dosimetry. Proton therapy and other accelerators business contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, and the Rest of the World, with REst-of-World sales generating the largest proportion of revenue.

Ion Beam Applications (XBRU:IBAS) Headlines

No Headlines